 |
|
|
|
|
H1N1 Interim Guidance for Adults with Cardiovascular
Disease
 One or more of the
following files are available in Portable Document Format (PDF).
Learn more about
PDFs.
The 2009-2010 flu season is upon us and many people are likely
to get ill with either the usual seasonal flu or 2009 H1N1 flu. People with
heart disease, cardiovascular disease, or who have had a stroke are at increased
risk of having medical complications of flu. The information in this document is
intended to help this group prevent getting seasonal and 2009 H1N1 flu and
provide guidance if they develop flu-like symptoms.
2009 H1N1 and Seasonal Flu: Interim Guidance for
Adults with Cardiovascular Disease
This document is also available for download
HERE.
[PDF-134K]
Clinicians and health departments should read
H1N1 Flu
and Adults with Cardiovascular Disease (Heart Disease and Stroke): Guidance
and Considerations for Health Care Providers and for State and Local Public
Health Agencies, and visit
http://www.cdc.gov/flu/freeresources/print.htm.
2009 H1N1 Flu (Formerly Called “Swine Flu”) and Seasonal
Flu: General Information
The information below is important for people with
cardiovascular disease.*
- Maintain a 2-week supply of your regular medications.
- Do not stop taking your regular medications without
first consulting your health care provider, especially if you get the
flu or a respiratory infection.
- People with heart failure should be alert to changes in
their breathing and should promptly report changes to their health care
provider.
- It is especially important to wash your hands often with
soap and water and follow other everyday hygienic actions to
prevent the spread of germs
that cause respiratory illnesses like the flu.
- If you
have symptoms of the flu (i.e., fever, cough, sore throat, runny or
stuffy nose, body aches, headache, chills and fatigue) and you have
heart disease, stroke, or cardiovascular disease, promptly contact your
health care provider to see if you need antiviral medication. Influenza
antiviral medications can reduce the severity and duration of influenza
illness and can reduce the risk of influenza-related complications.
Information on antiviral medication recommendations is available at
http://www.cdc.gov/h1n1flu/recommendations.htm.
*Cardiovascular disease includes but is not limited to heart
failure, angina, peripheral vascular disease, atrial fibrillation or other
heart rhythm abnormalities, stroke, and heart attack, and adults with
congenital heart disease.
Influenza Vaccine Guidance for Adults
If you have a history
of heart
disease, stroke, or other
cardiovascular diseases*... |
Then... |
| And are between the ages of 25–64 years… |
- You should get your annual (seasonal) flu shot now, and
- Get the 2009 H1N1 monovalent vaccine when available.
|
| And are 65 years or older… |
- You should get your annual (seasonal) flu shot now, and
- Get the2009 H1N1 monovalent vaccine when available for
persons 65 years or older.
|
For More Information
Return to top
H1N1 Influenza and
Adults with Cardiovascular Disease
This document is also available for download
HERE.
[PDF-156K]
People with
cardiovascular disease are at increased risk of having medical complications
of influenza. The information in this document is intended to help this
group prevent getting seasonal and 2009 H1N1 influenza and provide guidance
if they develop influenza-like symptoms.
Guidance and
Considerations for Health Care Providers and for State and Local Public
Health Agencies
- People
with chronic cardiovascular disease and cerebrovascular disease (CVD)
are at increased risk of experiencing an acute exacerbation of disease
during influenza epidemics.1–7
- People
with chronic cardiovascular disease are at higher risk for both seasonal
and 2009 H1N1 influenza-related complications.
-
Consideration should be given for having adequate supplies of commonly
used cardiovascular medications for preventing and treating
cardiovascular events.8
- Health
care providers should be aware that 2009 H1N1 influenza and seasonal
influenza might produce increased numbers of cardiovascular events,
leading to increased hospitalizations and use of resources to treat
acute coronary events, heart failure, and stroke.9–11
- Early
empiric use of influenza antiviral medication is recommended for those
at increased risk of influenza complications
who present with influenza-like symptoms. This includes adults aged 65
years or older and people with cardiovascular disease. See http://www.cdc.gov/h1n1flu/antiviral.htm
for more information.
Vaccination Recommendations for
Adults with Cardiovascular Disease
Seasonal Influenza Vaccine
- All
patients with cardiovascular disease, including those ≥ 65 years, should
receive the seasonal (annual) influenza vaccine as soon as it is
available. Detailed information on seasonal (annual) influenza
immunization guidelines are available at
http://www.cdc.gov/flu/professionals/acip/
2009 H1N1 Monovalent Influenza
Vaccine
-
Patients aged 25-64 years with cardiovascular disease are considered a
target group for 2009 H1N1 influenza vaccine and should be vaccinated as
soon as vaccine is available.
-
Patients aged ≥ 65 years with or without cardiovascular disease are not
considered an initial vaccine target group for 2009 H1N1 influenza, but
should be vaccinated as more 2009 H1N1 influenza vaccine becomes
available.
-
Additional 2009 H1N1 influenza vaccine target groups include pregnant
women, household contacts and caregivers for children younger than 6
months of age, healthcare and emergency medical services personnel, and
all people from 6 months through 24 years of age.
For More Information
References
- Madjid
M, Naghavi M, Litovsky S, Casscells SW. Influenza and cardiovascular
disease: a new opportunity for prevention and the need for further
studies. Circulation 2003;108:2730–2736.
- Nichol
KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza
vaccination and reduction in hospitalizations for cardiac disease and
stroke among the elderly. N Engl J Med 2003;348(14):1322–1332.
-
Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Influenza vaccine
pilot study in acute coronary syndromes and planned percutaneous
coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS)
Study. Circulation 2002;05(18):2143–2147.
-
Ciszewski A, Bilinska ZT, Brydak LB, et al. Influenza vaccination in
secondary prevention from coronary ischaemic events in coronary artery
disease: FLUCAD study. Eur Heart J 2008;29(11):1350–1358.
-
Lavallee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P.
Association between influenza vaccination and reduced risk of brain
infarction. Stroke 2002;33(2):513–518.
- Madjid
M, Aboshady I, Awan I, Litovsky S, Casscells SW. Influenza and
cardiovascular disease: is there a causal relationship? Tex Heart
Inst J 2004;31:4–13.
- Madjid
M, Curkendall S, Blumentals WA. The influence of oseltamivir treatment
on the risk of stroke after influenza infection. Cardiology
2008;113(2):98–107.
- Madjid
M, Casscells SW. Of birds and men: cardiologists' role in influenza
pandemics. Lancet 2004;364(9442):1309.
- Mensah
GA, Grant AO, Pepine CJ, et al. ACCF/AHA/CDC conference
report on emerging infectious diseases and biological terrorism threats:
the clinical and public health implications for the prevention and
control of cardiovascular diseases. J Am Coll Cardiol
2007;49(12):1373–1412.
- Smeeth
L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of
myocardial infarction and stroke after acute infection or vaccination.
N Engl J Med 2004;351(25):2611–2618.
- Madjid
M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute
respiratory disease activity are associated with a surge in
autopsy-confirmed coronary heart disease death: results from 8 years of
autopsies in 34,892 subjects. Eur Heart J 2007;28(10):1205–1210.
Return to top
Page last reviewed: November 13, 2009
Page last modified: November 13, 2009
Content source: Division for Heart Disease and Stroke
Prevention,
National Center for Chronic Disease Prevention and
Health Promotion |
|
